May 6, 2022
by Bohdana Sokolova, Andrii Buvailo
Biopharma insight
As of now, only 5% of so-called rare diseases (orphan diseases) have an FDA-approved treatment available to patients. Rare diseases …
May 5, 2022
by Basem Goueli, M.D., Ph.D., MBA
Biopharma insight
We are witnessing a revolution in cancer therapeutics that is truly bewildering. The number of novel drugs with unique mechanisms …
May 4, 2022
by Bohdana Sokolova
Undefined
Ever since the early 2000s, Artificial Intelligence (AI) has become a useful tool in various fields, from game design and …
May 3, 2022
by Andrii Buvailo
Interview
The digitalization of clinical trials and the adoption of artificial intelligence (AI) has been a hot topic for a number …
April 28, 2022
by Henk Johan Streefkerk
Biopharma insight
This post was originally published on Quora, answering the question: "How do drug manufacturers select the right contract research organization(CRO)?" …
April 26, 2022
by Andrii Buvailo
Interview
Quantum computing is a growing trend due to recent major advances in hardware making this technology a practically feasible thing. …
April 25, 2022
by Andrii Buvailo
Biopharma insight
What is “artificial intelligence”? Artificial intelligence (AI) is an interdisciplinary science concerned with building “intelligent agents”, the field which takes …
April 21, 2022
by Basem Goueli, MD, PhD, MBA
Biopharma insight
I always think of the Jeff Goldblum quote in Jurassic Park where he says "life finds a way" when I …
April 20, 2022
by Andrii Buvailo
Interview
Sponsored by Standigm
There is a new generation of tech-savvy drug discovery companies, applying the power of artificial intelligence (AI) to accelerate and …
April 18, 2022
by Andrii Buvailo
Interview
Sponsored by Promega
There is a new wave of innovation that is sweeping through pharmaceutical drug discovery: targeted protein degradation (TPD). TPD is …
April 14, 2022
by Andrii Buvailo
Interview
Dr. Tony Kulesa is the co-founder of Petri, an organization that both invests in early-stage biotech startups and works 1-on-1 …
April 7, 2022
by Irina Bilous, Andrii Buvailo
Biopharma insight
The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% …